Viewing data from:

POLOCAINE

ANDA

MEPIVACAINE HYDROCHLORIDE | A088653 | DENTSPLY PHARMACEUTICAL

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Polocaine (2023)

Total Spending

$19K

Total Claims

2,004

Beneficiaries

1,196

ASP Price

—

HCPCS: J0670 — Injection, mepivacaine hydrochloride, per 10 ml

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain2 active DMFs

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

MOEHS IBERICA SLMEPIVACAINE HYDROCHLORIDE

DMF 199912006

PCASMEPIVACAINE HYDROCHLORIDE

DMF 350132020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 3%

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Aug 21, 1984

No patent or exclusivity listings for this strength.